American Regent
The Pharmacovigilance Manager, Aggregate & Trend Reports oversees periodic aggregate, trend, and signal detection reporting for human and veterinary drug products to support safety assessment and regulatory submissions. Reporting to the Medical Director, Pharmacovigilance, the role provides aggregate safety data and insights used in product risk–benefit evaluations and regulatory communications.
Headquarters
Shirley, New York, United States
Company Size
501-1000 employees
Founded
1910
American Regent is a pharmaceutical company dedicated to developing and reliably delivering essential injectable medicines for both human and animal health. Their product portfolio includes a wide range of injectable drugs such as Epinephrine, Venofer® (iron sucrose injection), Injectafer®, and many other USP-grade medications. headquartered in Shirley, NY, American Regent is a subsidiary of the Daiichi Sankyo Group.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for American Regent.
Adequan, the “Official Joint Therapy Treatment,” Continues…
Jun 9, 2025
Director, Drug Safety & Pharmacovigilance
Xencor
Global Pharmacovigilance Manager
Amgen
Pharmacovigilance Aggregate Reporting Lead
Med Communications
Senior Director, Patient Safety & Pharmacovigilance
Latigobio
Director, Drug Safety & Pharmacovigilance - Safety Scientist
Travere Therapeutics
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
IQVIA